ARK Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-39,131
Closed -$4.86M 309
2021
Q2
$4.86M Sell
39,131
-665
-2% -$83.5K 0.01% 240
2021
Q1
$4.7M Buy
39,796
+30,977
+351% +$3.63M 0.01% 236
2020
Q4
$1.03M Buy
8,819
+4,638
+111% +$511K ﹤0.01% 215
2020
Q3
$434K Buy
4,181
+1,392
+50% +$140K ﹤0.01% 189
2020
Q2
$256K Buy
2,789
+245
+10% +$23.5K ﹤0.01% 187
2020
Q1
$229K Sell
2,544
-258
-9% -$27.4K 0.01% 166
2019
Q4
$318K Sell
2,802
-814
-23% -$89.3K 0.01% 184
2019
Q3
$393K Sell
3,616
-914
-20% -$95.4K 0.01% 166
2019
Q2
$441K Sell
4,530
-254
-5% -$23.2K 0.01% 150
2019
Q1
$436K Sell
4,784
-36
-0.7% -$3.22K 0.01% 149
2018
Q4
$438K Sell
4,820
-1,768
-27% -$165K 0.02% 126
2018
Q3
$648K Buy
+6,588
New +$609K 0.02% 115

Other funds holding MDT

ARK Investment Management's MDT Position: Q3 2021 in Review

ARK Investment Management sold out of Medtronic (MDT) in Q3 2021, closing a stake of 39,131 shares — an estimated $4.86M sold.

ARK Investment Management first reported a position in MDT in Q3 2018 and held it in 12 quarters. The position peaked at $4.86M in Q2 2021. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

  • ARK Investment Management reported no remaining Medtronic position as of Q3 2021 after selling out during the quarter.
  • ARK Investment Management sold 39,131 Medtronic shares in Q3 2021, an estimated $4.86M.
  • ARK Investment Management first reported a position in Medtronic in Q3 2018 and held it in 12 quarters.
  • ARK Investment Management's Medtronic position peaked at $4.86M in Q2 2021.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on ARK Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.